fda remove semaglutide from shortage list As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Hims stock plunges as Lilly's

Patients with Significant Liver Involvement: Those diagnosed with hepatic steatosis (fatty liver) or early-stage MASH, due to the potent anti-fat effects of the glucagon component on the liver

Our patient-first approach eases the process and builds confidence

We find that while almost all patients tolerate this treatment very well, some can titrate more quickly leading to faster results

Future Risks and Inflection Points Five forces are reshaping the AI supplement answer surface over the next 12 to 24 months

Plenty of generic medication reminders exist, but Pep is purpose-built for GLP-1 users

Diabetics who use GLP-1s tend to secrete more insulin to lower their blood sugar, further inflaming the pancreas and resulting in pancreatitis